The Latest Breaking News from Medicare

WASHINGTON — Senate Democrats on Sunday passed a sweeping health care, tax and climate change bill that will allow Medicare to negotiate prescription drug costs — a significant political win as the party tries to send a message before the midterm election that it is delivering on its promises.

The estimated $740 billion package heads next to the House, where lawmakers are poised to deliver on Biden’s priorities.

The legislation – which would be the largest investment yet in combating the climate crisis – now heads to the House of Representatives.

Inflation Reduction Act will reduce planet-heating emissions and lower prescription drug costs – and give Biden a crucial victory

The $35 price cap on insulin was removed by GOP senators for users of private insurance, but remains for Medicare

Seven Republicans voted with Democrats to keep the insulin cap, but it wasn't enough to overcome the 60-vote threshold.

After a year of negotiations, impasses and political maneuvering, the Senate passed Democrats' top domestic priority.

The Senate worked through the night making steps on the bill that will then go on to Biden to sign into law

Senate Democrats spent the weekend advancing what they call a historic piece of legislation, but it's still a much smaller version of what they — and President Biden — originally called for.

Democrats are driving their election-year economic package toward Senate approval

Senate Democrats stuck together and mostly voted against amendments to their tax, climate and health care package.